Lozol and Catapres drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lozol (indapamide) and Catapres (clonidine hydrochloride). Common drug interactions include limb injury among females and pulmonary oedema among males.
The phase IV clinical study analyzes what interactions people have when they take Lozol and Catapres. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Lozol?
Lozol has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 1,652 Lozol users. Check the latest studies of Lozol.
What is Catapres?
Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,680 Catapres users. Check the latest studies of Catapres.
20 people who take Lozol and Catapres together, and have interactions are studied.

What are the common drug interactions of Lozol and Catapres, by gender? *:
female:
- Limb injury
- Nausea (feeling of having an urge to vomit)
- Sleep disorder
- Small intestinal obstruction (blockage in small intestine)
- Stress
- Abdominal pain
- Arthropathy
- Asthenia (weakness)
- Asthma
- Breast calcifications (deposits of calcium that can be seen on a mammogram of the breast)
male:
- Pulmonary oedema (fluid accumulation in the lungs)
- Eye haemorrhage (bleeding in the eye)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Tricuspid valve incompetence (inefficient heart valve)
- Arteriosclerosis (thickening and hardening of arteries)
- Asthenia (weakness)
- Balance disorder
- Cardiac murmur (an heart sound in valve abnormality)
- Congestive cardiomyopathy (weakening of heart muscle)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
What are the common drug interactions of Lozol and Catapres, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Asthenia (weakness)
- Chest pain
- Dyspnoea (difficult or laboured respiration)
- Gastric disorder (disease of stomach)
- Hemiparesis (weakness on one side of the body)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Asthma
- Headache (pain in head)
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Overdose
50-59:
- Spondylolisthesis (displacement of a vertebra or the vertebral column in relation to the vertebrae below)
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Chest pain
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Eye haemorrhage (bleeding in the eye)
- Hypotension (abnormally low blood pressure)
- Intervertebral disc protrusion (spinal disc protrusion)
- Localised osteoarthritis (infection of joint affects only single joint)
60+:
- Cerebellar infarction (impaired blood circulation to cerebellum)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Labile hypertension (wildly fluctuating blood pressure)
- Carotid artery atheroma (swelling of artery wall)
- Diarrhoea
- Digoxin toxicity
- Encephalomalacia (localized softening of the brain substance, due to haemorrhage or inflammation)
- Flatulence (flatus expelled through the anus)
- Lacunar infarction (a type of stroke)
What are the existing conditions these people have? *
- High Blood Cholesterol: 3 people, 15.00%
- Pain: 2 people, 10.00%
- Diabetes: 2 people, 10.00%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 10.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.00%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 5.00%
- Indigestion: 1 person, 5.00%
- Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 1 person, 5.00%
- Hypocalcaemia (levels of calcium in blood serum are abnormally low): 1 person, 5.00%
- Dyspnea (difficult or laboured breathing): 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Lozol and Catapres?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lozol and Catapres:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lozol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Catapres:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lozol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Catapres and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on indapamide and clonidine hydrochloride (the active ingredients of Lozol and Catapres, respectively), and Lozol and Catapres (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tasigna cause Haematuria Aggravated? - 4 seconds ago
- Eye Pain in Glumetza, how severe and when it was recovered? - 7 seconds ago
- Phentermine and Neurontin drug interactions for women aged 50-59 - 10 seconds ago
- Norvasc and Nasopharyngitis for Women aged 30-39 - 11 seconds ago
- Could Ticagrelor cause Tendonitis? - 12 seconds ago
- Novalgin vs. Ambien, side effect and effectiveness comparison - 14 seconds ago
- Urticaria and Drug Ineffective - 16 seconds ago
- Could Nph Insulin cause Hair Loss? - 20 seconds ago
- Drug interactions of Prednisone and Marinol - 20 seconds ago
- Depakene vs. Zarontin, side effect and effectiveness comparison - 24 seconds ago